Lv4
662 积分 2024-06-19 加入
Clinical prospective study of Gallium 68 (68Ga)–labeled fibroblast-activation protein inhibitor PET/CT in the diagnosis of biliary tract carcinoma
1天前
已完结
The diagnostic value of 18 F-FAPI-04 PET/CT in unresectable hepatocellular carcinoma: a head-to-head comparison with 18 F-FDG PET/CT
1天前
已完结
Comparison of 68Ga-DOTA-FAPI and 18FDG PET/CT imaging modalities in the detection of liver metastases in patients with gastrointestinal system cancer
2天前
已完结
Clinical study on bile excretion pattern of [18F]AlF-FAPI-74 and measures to eliminate its physiological uptake in the hepatobiliary system
2天前
已完结
FAP-Targeted PET/CT with [18F]AlF-NOTA-FAPI-04 in Hepatocellular Carcinoma: Prospective Correlation of Fibrosis Quantification with Treatment Response and Survival Outcomes
2天前
求助中
Mismatch of FAPI PET/CT and FDG PET/CT in evaluating TARE treatment on a rat model of liver cancer
2天前
已完结
18F-FAPI PET/CT in chronic liver disease: myocardial fibroblast activation and its correlates
2天前
已完结
Semiquantitative analysis of 18F-aluminum fluoride fibroblast activation protein inhibitor 42 PET/computed tomography in primary liver cancer and factors influencing imaging positivity rates
2天前
已完结
Diagnostic efficacy of [68Ga]Ga-DOTA-GPFAPI-04 in patients with solid tumors in a head-to-head comparison with [18F]F-FDG: results from a prospective clinical study
2天前
已完结
The Value of Machine Learning-based Radiomics Model Characterized by PET Imaging with 68Ga-FAPI in Assessing Microvascular Invasion of Hepatocellular Carcinoma
2天前
已完结
皖公网安备34019202002308
